There are several oncogenic proteins such as EPHA3 and RSPO1, RSPO2, and RSPO3, which are overexpressed in lung adenocarcinomas and lymphoblastic leukemia and define the patient’s survival rates [80,81,82]. Here, RSPO2 is linked to lung adenocarcinoma.